• Fri, April 7, 2017

by: WOPRAI

Joe Feldman Upgraded (WMT) to Buy and Increased Target to $27 on, Apr 7th, 2017

by: WOPRAI

Heiko Ihle Reiterated (WRN) at Strong Buy and Held Target at $2 on, Apr 7th, 2017

by: WOPRAI

Mark Levin Initiated (BTU) at Hold on, Apr 7th, 2017

by: WOPRAI

Richard Gross Upgraded (SUN) to Buy and Increased Target to $35 on, Apr 7th, 2017

by: WOPRAI

Mark Murphy Upgraded (TWLO) to Buy on, Apr 7th, 2017

by: WOPRAI

Tiffany Kanaga Upgraded (BKE) to Hold and Increased Target to $16 on, Apr 7th, 2017

by: WOPRAI

Andrew Wittmann Downgraded (ACM) to Hold and Decreased Target to $40 on, Apr 7th, 2017

by: WOPRAI

Michael Scialla Initiated (APA) at Hold and Held Target at $54 on, Apr 7th, 2017

by: WOPRAI

Jeff Kvaal Downgraded (ANET) to Hold on, Apr 7th, 2017

  • Thu, April 6, 2017

by: WOPRAI

Rajeev Lalwani Downgraded (AL) to Hold and Held Target at $42 on, Apr 6th, 2017

by: WOPRAI

Ross Muken Upgraded (CAH) to Buy on, Apr 6th, 2017

by: WOPRAI

Seth Weiss Upgraded (AFL) to Hold on, Apr 6th, 2017

by: WOPRAI

Rajeev Lalwani Downgraded (AER) to Sell and Held Target at $44 on, Apr 6th, 2017

by: WOPRAI

Ann Duignan Downgraded (BG) to Sell on, Apr 6th, 2017

by: WOPRAI

Adam Ilkowitz Upgraded (BCE) to Strong Buy on, Apr 6th, 2017

by: WOPRAI

Toshiya Hari Initiated (AMD) at Strong Sell and Held Target at $11 on, Apr 6th, 2017

by: WOPRAI

Rhem Wood Initiated (ALSN) at Hold on, Apr 6th, 2017

by: WOPRAI

Brian Johnson Reiterated (TSLA) at Sell and Held Target at $11 on, Apr 6th, 2017

by: WOPRAI

Stephen Biggar Initiated (SNY) at Strong Buy and Held Target at $50 on, Apr 6th, 2017

by: WOPRAI

Michael Rose Upgraded (TCBI) to Strong Buy on, Apr 6th, 2017

by: WOPRAI

Steven Halper Downgraded (TDOC) to Hold on, Apr 6th, 2017

by: WOPRAI

Michael Rose Initiated (CFR) at Hold on, Apr 6th, 2017

by: WOPRAI

Matthew Niknam Downgraded (TMUS) to Hold on, Apr 6th, 2017

by: WOPRAI

Alex Kramm Initiated (SSNC) at Strong Buy and Held Target at $41 on, Apr 6th, 2017

  • Mon, April 10, 2017

by: WOPRAI

USA Technologies Inc. (NASDAQ:USAT), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our R

by: WOPRAI

Lannett Company Inc. (NYSE:LCI), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Repor

by: WOPRAI

Champions Oncology Inc. (NASDAQ:CSBR), Up By $0.98 (46.39%) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, April

by: WOPRAI

VDTH SqueezeTrigger Price is $8.97. There is $137,391 That Short Sellers Still Need To Cover.

by: WOPRAI

PFBX SqueezeTrigger Price is $13.27. There is $46,560 That Short Sellers Still Need To Cover.

by: WOPRAI

WINS SqueezeTrigger Price is $55.05. There is $6,764,375 That Short Sellers Still Need To Cover.

by: WOPRAI

KTEC SqueezeTrigger Price is $12.91. There is $35,505 That Short Sellers Still Need To Cover.

by: WOPRAI

OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlin

by: WOPRAI

Golden Minerals Company (NYSE:AUMN), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In O

by: WOPRAI

NF Energy Saving Corporation (NASDAQ:NFEC), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlin

by: WOPRAI

DryShips Inc. (NASDAQ:DRYS), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repor

by: WOPRAI

Rosetta Stone Inc. (NYSE:RST), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

WellCare Health Plans Inc. (NYSE:WCG), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our

by: WOPRAI

Gemphire Therapeutics (NASDAQ:GEMP), Up By $1.49 (14.28%) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, April 5

by: WOPRAI

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In

by: WOPRAI

Central Securities Corp (NYSE:CET), Up By $3.13 (14.98%) After BUYINS.NET SqueezeTrigger Report Released on Friday, April 7th 2

by: WOPRAI

Amir Rozwadowski Upgraded (AMX) to Buy on, Apr 10th, 2017

by: WOPRAI

Kerry Rice Upgraded (AMZN) to Strong Buy and Held Target at $50 on, Apr 10th, 2017

by: WOPRAI

Stan Meyers Downgraded (AMCX) to Hold on, Apr 10th, 2017

by: WOPRAI

Alexander Potter Upgraded (TSLA) to Buy and Increased Target to $25 on, Apr 10th, 2017

by: WOPRAI

Christopher Sighinolfi Upgraded (SUN) to Hold and Increased Target to $29 on, Apr 10th, 2017

by: WOPRAI

Ethan Bellamy Upgraded (SUN) to Buy and Increased Target to $36 on, Apr 10th, 2017

by: WOPRAI

Anthony Chukumba Upgraded (ULTA) to Strong Buy on, Apr 10th, 2017

by: WOPRAI

Kevin Barker Upgraded (WFC) to Hold on, Apr 10th, 2017

Ross Muken Upgraded (CAH) to Buy on, Apr 6th, 2017

Ross Muken of Evercore ISI Group, Upgraded "Cardinal Health, Inc." (CAH) to Buy on, Apr 6th, 2017.

Ross has made no other calls on CAH in the last 4 months.



There are 2 other peers that have a rating on CAH. Out of the 2 peers that are also analyzing CAH, all agree with Ross's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Ann Hynes of "Mizuho" Downgraded from Strong Buy to Hold on, Tuesday, January 3rd, 2017
  • David Larsen of "Leerink Swann" Downgraded from Buy to Hold on, Wednesday, December 21st, 2016